Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers (Q45420926)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

human parainfluenza

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Clare L. Cutland

object named as

Clare Cutland

2

0 references

Shabir A. Madhi

1

object named as

Shabir A Madhi

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Robert B Belshe

8

object named as

Robert B Belshe

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

9

object named as

Ruth A Karron

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

William C. Gruber

11

object named as

William C Gruber

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Frances K. Newman

5

object named as

Frances Newman

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

10

object named as

Anne M Deatly

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

4

object named as

Jill G Hackell

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Brian R. Murphy

7

object named as

Brian R Murphy

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

David I Bernstein

12

object named as

David I Bernstein

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Yuwei Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nigel Blackburn

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Peter F Wright

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

20 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2432-2439

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Respiratory syncytial virus and parainfluenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Protective effect of antibody to parainfluenza type 1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Evaluation of cold-adapted adn temperature-sensitive mutants of parainfluenza virus type 3 in weanling hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

A cold-adapted mutant of parainfluenza virus type 3 is attenuated and protective in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

On the Statistical Measure of Infectiousness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

A commentary on the mechanical analogue to the Reed-Frost epidemic model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.12.002

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45420926&oldid=2146976143"